Nicodil preconditioning improves cardiac function in rat models of diabeties complicated with coronary heart disease

doi:10.16352/j.issn.1001-6325.2026.03.0388

Abstract

Abstract: Objective To identify the impacts of nicorandil (Nic) on cardiac function of rats with diabetes mellitus and coronary heart disease (DM/CHD) and to explore the potential mechanism. Methods Rats were divided into: control group, DM/CHD group, DM/CHD+Nic group and DM/CHD+Nic+shTRPV1 group. The cardiac function parameters were detected by electrocardiogram. Blood was collected for biochemical index detection. Cardiac histo-pathological changes, collagen deposition and apoptosis were determined by HE, Masson trichrome and TUNEL staining microcopy respectively. The protein expression was analyzed by Western blot. Results In comparation to control group, the cardiomyocyte diameter and collagen accumulation were increased (P＜0.05). Apoptotic cells and the expression of Bax and cleaved caspase-3 were increased (P＜0.05),expression of Bcl-2, TRPV1, p-PI3K and p-Akt was decreased. Compared with DM/CHD group, myocardial cell diameter and collagen accumulation were reduced (P＜0.05). Apoptotic cells and the level of Bax and cleaved caspase-3 were reduced (P＜0.05).The expression of Bcl-2, TRPV1, p-PI3K and p-Akt was enhanced (P＜0.05). Compared with DM/CHD+Nic group, myocardial cell diameter and collagen accumulation were increased (P＜0.05). Apoptotic cells and the expression of Bax and cleaved caspase-3 were up-regulated (P＜0.05).The expression of Bcl-2, TRPV1, p-PI3K and p-Akt was down-regulated. Conclusions Nic improves cardiac function in DM/CHD rats with potential mechanism of regulating TRPV1-PI3K/Akt signaling pathway.

Key words: nicorandil, TRPV1, PI3K/Akt, diabetes mellitus with coronary heart disease, cardiac function

CLC Number:

R587.2

BIAN Ya, GUO Jie, CAO Weiguang, LYU Xiaomian. Nicodil preconditioning improves cardiac function in rat models of diabeties complicated with coronary heart disease[J]. Basic & Clinical Medicine, 2026, 46(3): 388-395.

References

[1] Zarkasi KA, Abdul Murad NA, Ahmad N, et al. Coronary heart disease in type 2 diabetes mellitus: genetic factors and their mechanisms, gene-gene, and gene-environment interactions in the Asian populations[J]. Int J Environ Res Public Health, 2022, 19:647. doi: 10.3390/ijerph19020647.
[2] Wang X, Chen H. Efficacy and safety of nicorandil in the treatment of stable angina pectoris[J]. Altern Ther Health Med, 2024, 30:130-135.
[3] Chen Z, Li S, Liu M, et al. Nicorandil alleviates cardiac microvascular ferroptosis in diabetic cardiomyopathy: role of the mitochondria-localized AMPK-Parkin-ACSL4 signaling pathway[J]. Pharmacol Res, 2024, 200:107057. doi: 10.1016/j.phrs.2024.107057.
[4] Wang X, Pan J, Liu D, et al. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway[J]. J Cell Mol Med, 2019, 23:5349-5359.
[5] Yao E, Luo L, Lin C, et al. OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1[J]. Front Pharmacol, 2022, 13:964475. doi: 10.3389/fphar.2022.964475.
[6] 姜小雪, 刘关羽, 雷寒, 等. PI3K/Akt通路介导TRPV1抑制离体小鼠心脏缺血再灌注后的细胞凋亡[J]. 基础医学与临床, 2016, 36: 1187-1192.
[7] 罗兵. 冠心消渴安胶囊对糖尿病合并冠心病大鼠模型胰岛素抵抗和炎性指标的影响[D]. 郑州:河南中医药大学, 2016: 10.
[8] Singh D, Singh R, Akindele AJ. Therapeutic potential of nicorandil beyond anti-anginal drug: a review on current and future perspectives[J]. Heliyon, 2024, 10:e28922. doi: 10.1016/j.heliyon.2024.e28922.
[9] Yoshie K, Rajendran PS, Massoud L, et al. Cardiac TRPV1 afferent signaling promotes arrhythmogenic ventricular remodeling after myocardial infarction[J]. JCI Insight, 2020, 5:e124477. doi: 10.1172/jci.insight.124477.
[10] Shen YR, Cheng L, Zhang DF. TRPV1: A novel target for the therapy of diabetes and diabetic complications[J]. Eur J Pharmacol, 2024, 984:177021. doi: 10.1016/j.ejphar.2024.177021.
[11] Jia X, Yu T, Xiao C, et al. Expression of transient receptor potential vanilloid genes and proteins in diabetic rat heart[J]. Mol Biol Rep, 2021, 48:1217-1223.
[12] Deng RM, Zhou J. The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury[J]. Int Immunopharmacol, 2023, 123:110714. doi: 10.1016/j.intimp.2023.110714.
[13] Xia Z, Chen B, Zhou C, et al. Protective effect of ischaemic postconditioning combined with nicorandil on myocardial ischaemia-reperfusion injury in diabetic rats[J]. BMC Cardiovasc Disord, 2022, 22:518. doi: 10.1186/s12872-022-02967-1.
[14] Wu H, Ye M, Yang J, et al. Nicorandil protects the heart from ischemia/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through PI3K/Akt signaling pathway[J]. Cell Physiol Biochem, 2015, 35:2320-2332.
[15] He WK, Su Q, Liang JB, et al. Nicorandil pretreatment inhibits myocardial apoptosis and improves cardiac function after coronary microembolization in rats[J]. J Geriatr Cardiol, 2018, 15:591-597.